SEARCH

SEARCH BY CITATION

References

  • 1
    Meyer T, Arndt R, Christophers E et al. Association of rare human papillomavirus types with genital premalignant and malignant lesions. J Infec Dis 1998; 178: 252255.
  • 2
    Brown DR, Schroeder JM, Bryan JM, Stoler MH, Fife KH. Detection of multiple human papillomavirus types in condylomata acuminata lesions from otherwise healthy and immunosuppressed patients. J Clin Microbiol 1999; 37: 33163322.
  • 3
    Oriel JD. Natural history of genital warts. Br J Vener Dis 1971; 47: 113.
  • 4
    Cook LS, Koutsky LA, Holmes KK. Clinical presentation of genital warts among circumcised and uncircumcised heterosexual men attending an urban STD clinic. Genitourin Med 1993; 69: 262264.
  • 5
    Sonnex C, Schofield JH, Kocjan G et al. Anal human papillomavirus infection in heterosexuals with genital warts: prevalence and relation with sexual behaviour. Brit Med J 1991; 303: 1243.
  • 6
    Woodhall S, Ramsey T, Cai C et al. Estimation of the impact of genital warts on health-related quality of life. Sex Transm Inf 2008; 84: 161166.
  • 7
    Maw RD, Reitano M, Roy M. An international survey of patients with genital warts; perceptions regarding treatment and impact on lifestyle. Int J STD AID 1998; 9: 571578.
  • 8
    Armstrong N, Foley G, Wilson J, Finan P, Sebag-Montefiore D. Successful treatment of a large Buschke-Lowenstein tumour with chemo-radiotherapy. Int J STD AIDS 2009; 20: 732734.
  • 9
    Clinical Effectiveness Group (British Association for Sexual Health and HIV). United Kingdom National Guideline for the Management of Anogenital Warts, 2007. URL http://www.bashh.org/documents/86/86.pdf (Last accessed 27 February 2012).
  • 10
    Centers for Disease Control and Prevention. Sexually Transmitted Diseases Treatment Guidelines, 2010. MMWR 2010;59(No. RR-12): URL http://www.cdc.gov/std/treatment/2010/genital-warts.htm (Last accessed 27 February 2012).
  • 11
    US Department of Health and Human Services, Agency for Health Care Policy and Research. Acute pain management: operative or medical procedures and trauma. ClinicalPracticeGuidelinesNo1. AHCPR, Rockville, MD. Publication No 92-0023, 1993:107.
  • 12
    Von Krogh G, Szpak E, Andersson M et al. Self-treatment using 0.25–0.5% podophyllotoxin ethanol solutions against penile condylomata acuminate – a placebo-controlled comparative study. Genitourin Med 1994; 70: 105109.
  • 13
    Beutner KR, Conant MA, Friedman-Kien A. Patient-applied podofilox for treatment of genital warts. Lancet 1989;i:831834.
  • 14
    Kirby P, Dunne A, King DH, Corey L. Double-blind randomized clinical trial of self-administered podofilox solution versus vehicle in the treatment of genital warts. Am J Med 1990; 88: 465470.
  • 15
    Claesson U, Lassus A, Happonen H et al. Topical treatment of venereal warts: a comparative open study of podophyllotoxin cream versus solution. Int J STD AIDS 1996; 7: 429434.
  • 16
    Strand A, Brinkeborn R-M, Siboulet A. Topical treatment of genital warts in men, an open study of podophyllotoxin cream compared with solution. Genitourin Med 1995; 7: 387390.
  • 17
    Lacey CJ, Goodall RL, Tennvall GR et al. Randomised controlled trial and economic evaluation of podophyllotoxin solution, podophyllotoxin cream, and podophyllin in the treatment of genital warts. Sex Transm Infect 2003; 79: 270275.
  • 18
    Edwards A., Atma RA., T R.N. Podophyllotoxin 0.5% v podophyllin 20% to treat penile warts. Genitourin Med 1988; 64: 263265.
  • 19
    Mazurkiewicz W, Jablonska S. Clinical efficacy of condyline (0.5% podophyllotoxin) solution and cream versus podophyllin in the treatment of external condylomata acuminata. J Dermatol Treat 1990; 1: 123125.
  • 20
    Komericki P, Akkilic-Materna M, Strimitzer T, Aberer W. Efficacy and safety of imiquimod versus podophyllotoxin in the treatment of genital warts. Sex Transm Dis 2011; 38: 216218.
  • 21
    Beutner KR, Tyring SK, Trofatter KF Jr et al. Imiquimod, a patient-applied immune-response modifier for treatment of external genital warts. Antimicrob Agents Chemother 1998; 42: 789794.
  • 22
    Beutner KR, Spruance SL, Hougham AJ, Fox TL, Owens ML, Douglas JM Jr. Treatment of genital warts with an immune-response modifier (imiquimod). J Am Acad Dermatol 1998; 38: 230239.
  • 23
    Edwards L, Ferenczy A, Eron L et al. Self-administered topical 5% imiquimod cream for external anogenital warts. Arch Dermatol 1998; 134: 2530.
  • 24
    Fife KH, Ferenczy A, Douglas JM Jr et al. Treatment of external genital warts in men using 5% imiquimod cream applied three times a week, once daily, twice daily, or three times a day. Sex Transm Dis 2001; 28: 226231.
  • 25
    Garland SM, Waddell R, Mindel A, Denham IM, McCloskey JC. An open-label phase II pilot study investigating the optimal duration of imiquimod 5% cream for the treatment of external genital warts in women. Int J STD AIDS 2006; 17: 448452.
  • 26
    Schofer H, Van Ophoven A, Henke U, Lenz T, Eul A. Randomized, comparative trial on the sustained efficacy of topical imiquimod 5% cream versus conventional ablative methods in external anogenital warts. Eur J Dermatol 2006; 16: 642648.
  • 27
    Arican O, Guneri F, Bilgic K, Karaoglu A. Topical imiquimod 5% cream in external anogenital warts: a randomized, double-blind, placebo-controlled study. J Dermatol 2004; 31: 627631.
  • 28
    Einarson E, Costei A, Kalra S, Rouleau M, Koren M. The use of topical 5% imiquimod during pregnancy: a case series. Reprod Toxicol 2006; 21: 12.
  • 29
    Audisio T, Roca FC, Piatti C. Topical imiquimod therapy for external anogenital warts in pregnant women. Int J Gynaecol Obstet 2008; 100: 275276.
  • 30
    Gross G, Meyer KG, Pres H, Thielert C, Tawfik H, Mescheder A. A randomized, double-blind, four-arm parallel-group, placebo-controlled Phase II/III study to investigate the clinical efficacy of two galenic formulations of Polyphenon E in the treatment of external genital warts. J Eur Acad Dermatol Venereol 2007; 21: 14041412.
  • 31
    Tatti S, Stockfleth E, Beutner KR et al. Polyphenon E®: a new treatment for external anogenital warts. Br J Dermatol 2010; 162: 176184.
  • 32
    Stone KM, Becker TM, Hagdu A et al. Treatment of external genital warts: a randomised clinical trial comparing podophyllin, cryotherapy and electrodessication. Genitourin Med 1990; 66: 1619.
  • 33
    Godley MJ, Bradbeer CS, Gellan M et al. Cryotherapy compared with trichloracetic acid in treating genital warts. Genitourin Med 1987; 63: 390392.
  • 34
    Handley JM, Maw RD, Horner T, Lawther H, McNeill T, Dinsmore WW. Non-specific immunity in patients with primary anogenital warts treated with interferon alpha plus cryotherapy or cryotherapy alone. Acta Dermato-Venereologica 1992; 72: 3940.
  • 35
    Sherrard J, Riddell L. Comparison of the effectiveness of commonly used clinic-based treatments for external genital warts. Int J STD AIDS 2007; 18: 365368.
  • 36
    Gilson RJ, Ross J, Maw R, Rowen D, Sonnex C, Lacey CJ. A multicentre, randomised, double-blind, placebo controlled study of cryotherapy versus cryotherapy and podophyllotoxin cream as treatment for external anogenital warts. Sex Transm Inf 2009; 85: 514519.
  • 37
    Panici PB, Scambia G, Baiocchi G, Perrone L, Pintus C, Mancuso S. Randomized clinical trial comparing systemic interferon with diathermocoagulation in primary multiple and widespread anogenital condyloma. Obstet Gynecol 1989; 74: 393397.
  • 38
    Jensen SL. Comparison of podophyllin application with simple excision in clearance and recurrences of perianal condylomata acuminata. Lancet 1985;ii:11461148.
  • 39
    Khawaja HT. Treatment of condyloma acuminatum. Lancet 1986; i: 208209.
  • 40
    Khawaja HT. Podophyllin versus scissor excision in the treatment of perianal condylomata acuminata: a prospective study. Brit J Surg 1989; 76: 10671068.
  • 41
    Petersen CS, Weismann K. Quercetin and kaempherol: an argument against the use of podophyllin? Genitourin Med 1995; 71: 9293.
  • 42
    Lacey CJN. Therapy for genital human papillomavirus-related disease. J Clin Virol 2005; 32S: S82S90.
  • 43
    Yang J, Pu Y, Zeng Z, Yu Z, Huang N, Deng Q. Interferons for the treatment of genital warts: a systematic review. BMC Infect Dis 2009; 9: 156.
  • 44
    Kashima HK, Shah K. Recurrent respiratory papillomatosis: clinical overview and management principles. Obstet Gynecol Clin North Am 1987; 14: 581588.
  • 45
    Cusini M, Salmaso F, Zerboni R et al. 5% imiquimod cream for external anogenital warts in HIV-infected patients under HAART therapy. Int J STD AIDS 2004; 15: 1720.
  • 46
    Viazis N, Vlachogiannakos J, Vasiliadis K, Theodoropoulos I, Saveriadis A, Karamanolis DG. Earlier eradication of intra-anal warts with argon plasma coagulator combined with imiquimod cream compared with argon plasma laser alone: a prospective, randomised trial. Dis Colon Rectum 2007; 50: 21732179.
  • 47
    Saiag P, Bauhofer A, Bouscarat F et al. Imiquimod 5% cream for external genital or perianal warts in human immunodeficiency virus-positive patients treated with highly active antiretroviral therapy: an open-label, noncomparitve study. Br J Dermatol 2009; 161: 904909.
  • 48
    Wen LM, Estcourt CS, Simpson JM, Mindel A. Risk factors for the acquisition of warts: are condoms protective? Sex Transm Inf 1999; 75: 312316.
  • 49
    Manhart LE, Koutsky LA. Do condoms prevent genital HPV infection, external genital warts, or cervical neoplasia? A meta-analysis. Sex Transm Dis 2002; 29: 725735.
  • 50
    Winer RL, Hughes JP, Feng Q et al. Condom use and the risk of genital human papillomavirus infection in young women. N Engl J Med 2006; 354: 26452654.
  • 51
    Burchell A, Tellier P-P, Coutlee F, Hanley J, Franco E. Evidence for a protective effect of condoms against male-to-female transmission. 26th International Papillomavirus Conference, Montreal, 2010, Abstract P-622
  • 52
    Hogewoning CJ, Bleeker MC, van den Brule AJ et al. Condom use promotes regression of cervical intraepithelial neoplasia and clearance of human papillomavirus: a randomized clinical trial. Int J Cancer 2003; 107: 811816.
  • 53
    Bleeker MC, Hogewoning CJ, Voorhorst FJ et al. Condom use promotes regression of human papillomavirus-associated penile lesions in male sexual partners of women with cervical intraepithelial neoplasia. Int J Cancer 2003; 107: 804810.
  • 54
    Bleeker MC, Berkhof J, Hogewoning CJ et al. HPV type concordance in sexual couples determines the effect of condoms on regression of flat penile lesions. Br J Cancer 2005; 92: 13881392.
  • 55
    Reynolds M, Fraser PA, Lacey CJN. Audits of the treatment of genital warts: closing the feedback loop. Int J STD AIDS 1996; 7: 347352.
  • 56
    Kjaer SK, Tran TN, Sparen P et al. The burden of genital warts: a study of nearly 70,000 women from the general female population in the 4 Nordic countries. J Infec Dis 2007; 196: 14471454.
  • 57
    Hansen BT, Kjaer SK, Munk C et al. Early smoking initiation, sexual behaviour and reproductive health – a large population-based study of Nordic women. Prev Med 2010; 51: 6872.